Study examining the prognostic factors involved in relapse following treatment with R-CHOP
Home / Resource Library / Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: An analysis of patients treated on the RICOVER-60 trial
Study examining the prognostic factors involved in relapse following treatment with R-CHOP